Shweta R. Motiwala

Dr. Shweta R. Motiwala


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2023 in JACC: Heart Failure
Verified
Journal Article
Closed access
SMShweta R. Motiwala
Shweta R. Motiwala
MNMatthew Nayor
Matthew Nayor

18 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YWYu Wu
Yu Wu
LGLina Gao
Lina Gao
JLJose Lazo
Jose Lazo
BMBrandon Martinez
Brandon Martinez
SGSimran Grewal
Simran Grewal
TMTeresa De Marco
Teresa De Marco
Heart transplantation has significantly improved survival and enhanced the quality of life of patients with end-stage heart failure. Successful long-term outcomes are predicated on a collaborative effort among patients, transplant teams, and primary care providers (PCPs). Notably, PCPs are increasingly pivotal in post-transplant care, engaging in annual assessments, early recognition of complications, and referral, thus minimizing morbidity and mortality. This article highlights key considerations for PCPs, including indications for heart transplant, immunosuppressive therapy and infection prophylaxis, management of post-transplant complications, psychosocial and lifestyle adjustment, and family planning. This roadmap aims to empower PCPs to deliver optimal care and improve long-term outcomes for heart transplant recipients.

14 September 2026 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
CPChelsea Pan
Chelsea Pan
SMShweta R. Motiwala
Shweta R. Motiwala
LKLiviu Klein
Liviu Klein
JGJin Ge
Jin Ge
Patients with chronic heart failure are at increased risk of congestive hepatopathy, yet current clinical markers have limited predictive value. In this proof-of-concept study, we leveraged hemodynamic data from the CardioMEMS device to evaluate the association between pulmonary artery pressure and hepatic congestion, as assessed by Model for End-stage Liver Disease excluding international normalized ratio (MELD-XI) score and abdominal imaging findings. We demonstrate that cumulative mean pulmonary artery pressure (PAP) is associated with MELD-XI score, supporting the potential utility of longitudinal PAP monitoring in estimating hepatic dysfunction. The stronger association observed with cumulative mean PAP, compared with cross-sectional measurements, suggests that persistent venous congestion over time may be more relevant to hepatic injury than single time-point values.